Correction to: Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N 6-methyladenosine of PARP1 mRNA and downregulating PTEN
Main Authors: | Lei Yang, Yi Chen, Ning Liu, QianCheng Shi, Xiaodong Han, Weidong Gan, Dongmei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | https://doi.org/10.1186/s13045-021-01153-8 |
Similar Items
-
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N 6-methyladenosine of PARP1 mRNA and downregulating PTEN
by: Lei Yang, et al.
Published: (2021-03-01) -
The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
by: Ning Liu, et al.
Published: (2020-10-01) -
Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion
by: Paulo G. O. Salles, et al.
Published: (2005-06-01) -
Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma
by: Guangxi Sun, et al.
Published: (2021-09-01) -
A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
by: Hong Ye, et al.
Published: (2019-01-01)